Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06215222 · ClinicalTrials.gov registry record
Capsule Microbiota Sampling in IBS/Functional Gastrointestinal Disease
A clinical trial of Healthy and IBS - Irritable Bowel Syndrome, sponsored by Stanford University.
- Recruiting
- Registry status
- 40
- Enrollment target
- 1
- Study location
NCT06215222: Recruiting study of Healthy and IBS - Irritable Bowel Syndrome, sponsored by Stanford University.
NCT06215222 is a study of Healthy and IBS - Irritable Bowel Syndrome that is actively recruiting participants, run by Stanford University. The registered enrollment target is 40 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06215222, a study of Healthy and IBS - Irritable Bowel Syndrome, is actively recruiting participants, sponsored by Stanford University.
- RECRUITING
- Registry status
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
We will sample intestinal microbiota using a microbiome sampling capsule in Healthy, Irritable Bowel Syndrome (IBS), and Functional Gastrointestinal Disease.
Primary Outcome
Collection of 50ul of intestinal fluid from microbiome sampling capsules
Conditions Studied
Interventions
- OTHER Microbiota Sampling
Study Locations (1)
California
- Stanford Digestive Health Clinic - Redwood City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2023-11-16 |
| Est. Completion | 2026-12-01 |
What NCT06215222 shows while recruiting
NCT06215222 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (94% lower).
The record links to 4 conditions, with Healthy appearing as the primary indexed condition, and to 1 intervention - of which Microbiota Sampling is the first listed.
NCT06215222 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06215222 about?
NCT06215222 is a clinical study titled "Capsule Microbiota Sampling in IBS/Functional Gastrointestinal Disease". We will sample intestinal microbiota using a microbiome sampling capsule in Healthy, Irritable Bowel Syndrome (IBS), and Functional Gastrointestinal Disease.
What is the current status of trial NCT06215222?
This trial is currently recruiting. The enrollment target is 40 participants. The study started on 2023-11-16. Estimated completion is 2026-12-01.
What conditions does trial NCT06215222 study?
This clinical trial studies the following conditions: Healthy, IBS - Irritable Bowel Syndrome, Functional Gastrointestinal Disorders, Functional Bloating.
What interventions are being tested in trial NCT06215222?
The interventions under investigation include: Microbiota Sampling (OTHER).
Who is sponsoring clinical trial NCT06215222?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06215222 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06215222's enrollment target sits among peer trials
40 540th of 1090 higher than 513 of 1,090 other Healthy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Mapping Auricular Vagus Nerve Circuitry
RECRUITING · Early Phase 1
-
Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.
RECRUITING · Phase 1
-
A Study of LY3867070 in Healthy Participants
RECRUITING · Phase 1
-
The Modulatory Effect of Female Sex Hormones on Spinal Neuroplasticity
RECRUITING
-
Breathing & Blood Pressure
RECRUITING
-
Neuromodulation-assisted Ego-disengagement: The NEURO-EGO Study Stage 1
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI